Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

43.55
Delayed Data
As of 4:02pm ET
 -0.19 / -0.43%
Today’s Change
36.71
Today|||52-Week Range
45.58
+9.47%
Year-to-Date

Today’s Trading

Previous close43.74
Today’s open43.82
Day’s range43.43 - 44.19
Volume3,557,996
Average volume (3 months)3,232,079
Market cap$106.6B
Dividend yield5.06%
Data as of 4:02pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)+181.82%
Earnings growth (this year)+14.25%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)-3.66%
P/E ratioNM
Price/Sales2.70
Price/Book14.04

Competitors

 Today’s
change
Today’s
% change
ABBVAbbVie-0.11-0.17%
SNYSanofi+0.34+0.88%
BMYBristol-Myers Squibb+0.01+0.02%
AGNAllergan+1.62+0.69%
Data as of 4:02pm ET, 08/26/2016

Financials

Next reporting dateOctober 26, 2016
EPS forecast (this quarter)$0.76
Annual revenue (last year)$36.5B
Annual profit (last year)$12.8B
Net profit margin35.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Andrew Philip Witty
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts

Partner Offers

Search for Jobs